{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T22:33:05Z","timestamp":1784154785737,"version":"3.55.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/deed.de"},{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/deed.de"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s00108-026-02094-5","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T10:18:18Z","timestamp":1772705898000},"page":"30-34","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pr\u00e4ventionsfelder der Endokrinologie\/Diabetologie\u00a0\u2013 \u201eThe Big Five\u201c","Preventive fields in endocrinology\/diabetology\u2014The big five"],"prefix":"10.1007","volume":"67","author":[{"given":"Martin","family":"Pfohl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Reincke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Seufert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Feldkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Fassnacht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Merkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Tuckermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"key":"2094_CR1","unstructured":"World Health Organization. Regional Office for Europe. Prevention and control of iodine deficiency in the WHO European Region: adapting to changes in diet and lifestyle. World Health Organization. Regional Office for Europe.: https:\/\/iris.who.int\/handle\/10665\/376863 Accessed."},{"issue":"1","key":"2094_CR2","doi-asserted-by":"publisher","first-page":"R13","DOI":"10.1530\/EJE-21-0171","volume":"185","author":"MB Zimmermann","year":"2021","unstructured":"Zimmermann\u00a0MB, Andersson\u00a0M (2021) GLOBAL ENDOCRINOLOGY: Global perspectives in endocrinology: coverage of iodized salt programs and iodine status in 2020. Eur J Endocrinol 185(1):R13\u2013R21. https:\/\/doi.org\/10.1530\/EJE-21-0171","journal-title":"Eur J Endocrinol"},{"key":"2094_CR3","doi-asserted-by":"publisher","unstructured":"OECD (2025), The State of Cardiovascular Health in the European Union. https:\/\/doi.org\/10.1787\/ea7a15f4-en (2025). Accessed 23.2.26.","DOI":"10.1787\/ea7a15f4-en"},{"key":"2094_CR4","doi-asserted-by":"publisher","unstructured":"Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Back M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227-337. https:\/\/doi.org\/10.1093\/eurheartj\/ehab484","DOI":"10.1093\/eurheartj\/ehab484"},{"key":"2094_CR5","doi-asserted-by":"publisher","unstructured":"Mach F, Koskinas KC, Roeters van Lennep JE, Tokgozoglu L, Badimon L, Baigent C, et al. 2025 Focused Update of the 2019 ESC\/EAS Guidelines for the management of dyslipidaemias. Eur Heart J. 2025;46(42):4359-78. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf190","DOI":"10.1093\/eurheartj\/ehaf190"},{"issue":"Forthcoming","key":"2094_CR6","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3238\/arztebl.m2025.0174","volume":"122","author":"L Reitzle","year":"2025","unstructured":"Reitzle\u00a0L, Maier\u00a0B, Hoebel\u00a0J, Pawlowska-Phelan\u00a0D, Ludwig\u00a0M, Neuhauser\u00a0H (2025) Arterial Hypertension: The Incidence of Diagnosed Hypertension, 24-Hour Blood Pressure Measurement and Pharmacotherapy. An Analysis of Routine Health Insurance Data. Dtsch Arztebl Int 122(Forthcoming):681\u2013686. https:\/\/doi.org\/10.3238\/arztebl.m2025.0174","journal-title":"Dtsch Arztebl Int"},{"key":"2094_CR7","unstructured":"WHO (2021) global sodium benchmarks for different food categories. https:\/\/www.who.int\/publications\/i\/item\/9789240025097. Accessed 22.2.2026"},{"key":"2094_CR8","unstructured":"UK G:\u00a0Collection Sugar, salt and calorie reduction and reformulation. https:\/\/www.gov.uk\/government\/collections\/sugar-reduction Accessed 22.2.26."},{"key":"2094_CR9","unstructured":"SCOPE-21 report. International Osteoporosis Foundation. https:\/\/www.osteoporosis.foundation\/scope-2021 Accessed 22.2.26."},{"key":"2094_CR10","unstructured":"Prophylaxe, Diagnostik und Therapie der Osteoporose bei postmenopausalen Frauen und bei M\u00e4nnern ab dem 50.Lebensjahr. Leitlinie des Dachverbands der Deutschsprachigen Wissenschaftlichen Osteologischen Gesellschaften e.V. https:\/\/register.awmf.org\/assets\/guidelines\/183-001l_S3_Prophylaxe-Diagnostik-Therapie-der-Osteoporose_2023-11.pdf"},{"key":"2094_CR11","unstructured":"K\u00f6rperliches Training zur Frakturprophylaxe. S3-Leitlinie des Dachverbands Osteologie e.V. (DVO) https:\/\/register.awmf.org\/assets\/guidelines\/183-002m_S3_Training_Frakturprophylaxe_2025-02.pdf"},{"issue":"10122","key":"2094_CR12","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S0140-6736(17)32640-5","volume":"391","author":"L Shepstone","year":"2018","unstructured":"Shepstone\u00a0L, Lenaghan\u00a0E, Cooper\u00a0C, Clarke\u00a0S, Fong-Soe-Khioe\u00a0R, Fordham\u00a0R et\u00a0al (2018) Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial. Lancet 391(10122):741\u2013747. https:\/\/doi.org\/10.1016\/S0140-6736(17)32640-5","journal-title":"Lancet"},{"key":"2094_CR13","first-page":"8","volume-title":"Deutscher Gesundheitsbericht Diabetes","author":"E SeidelJabobs","year":"2025","unstructured":"SeidelJabobs\u00a0E, T\u00f6nnies\u00a0T, Rathmann\u00a0W (2025) Epidemiologie des Diabetes in Deutschland. In: Deutsche Diabetes Gesellschaft dDD\u2011H (ed) Deutscher Gesundheitsbericht Diabetes. Kirchheim, pp\u00a08\u201311"},{"key":"2094_CR14","unstructured":"Beyer A\u2011K, Baumert J, Thamm R, Maier B, Neuhauser H, Fuchs J, Kuhnert R, Hapke U (2021) Gesundheit in Deutschland aktuell (GEDA 2019\/2020-EHIS) \u2013 Hintergrund und Methodik. Journal of Health Monitoring 6(3). Robert Koch-Institut, Berlin."},{"issue":"8","key":"2094_CR15","first-page":"345","volume":"122","author":"J Seufert","year":"2025","unstructured":"Seufert\u00a0J (2025) Pr\u00e4vention der Adipositas: medizinische und sozialpolitische Perspektiven. Dtsch Arztebl 122(8):345\u201350","journal-title":"Dtsch Arztebl"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-026-02094-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-026-02094-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-026-02094-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T05:57:53Z","timestamp":1775541473000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-026-02094-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":15,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["2094"],"URL":"https:\/\/doi.org\/10.1007\/s00108-026-02094-5","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"value":"2731-7080","type":"print"},{"value":"2731-7099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]},"assertion":[{"value":"24 February 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.\u00a0Pfohl, M.\u00a0Reincke, J.\u00a0Seufert, J.\u00a0Feldkamp, M.\u00a0Fassnacht,  und J. Tuckermann geben an, dass kein Interessenkonflikt besteht. J.\u00a0Tuckermann ist Scientific Co-founder von MetaImmune GmbH. M.\u00a0Merkel hat Vortr\u00e4ge\/Reisekosten\/Honorare\/Forschungsgelder in den letzten 3 Jahren mit Bezug zum Thema erhalten: Sanofi, Amgen, Lilly, MSD, Berlin-Chemie, Novartis, Daiichi-Sankyo, Novo Nordisk, Bayer, Menarin.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}